|
|
||||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Institute of Pathology, University of Heidelberg, 69120 Heidelberg, Germany
2 Department of Oncology, Transplantation and Advanced Technologies in Medicine, Division of Surgical, Molecular and Ultrastructural Pathology, University of Pisa, Pisa 56100, Italy
3 Department of Oncology, Transplantation and Advanced Technologies in Medicine, Division of General and Transplantation Surgery, University of Pisa
Correspondence to:
Dr I Esposito
Institute of Pathology, University of Heidelberg, Im Neuenheimer Feld 220, 69120 Heidelberg, Germany; irene_esposito{at}med.uni-heidelberg.de
Background: Inflammatory cells contribute to the growth and spread of human malignancies by producing molecules that enhance tumour invasiveness.
Aims: To characterise the inflammatory infiltrate in pancreatic ductal adenocarcinoma and to analyse its contribution to angiogenesis and its prognostic relevance.
Methods: Immunohistochemistry was used to identify inflammatory cells and evaluate the expression of proangiogenic and prolymphangiogenic molecules (vascular endothelial growth factor A (VEGF-A), VEGF-C, and basic fibroblast growth factor (bFGF)) by inflammatory and cancer cells in 137 pancreatic cancers. Intratumorous microvessel density (IMD) was assessed using CD34 as an endothelial cell marker.
Results: There were significantly more mast cells and macrophages in pancreatic cancers than in normal pancreas and the number of mast cells directly correlated with the presence of lymph node metastases. However, there was no relation between numbers of infiltrating inflammatory cells and the presence of chronic pancreatitis (CP)-like changes in the parenchyma surrounding the tumour. Double immunostaining revealed that both pancreatic mast cells and macrophages express VEGF-A, VEGF-C, and bFGF. These factors were also expressed in the tumour cells in many cases. The numbers of VEGF-A expressing tumour cells and bFGF expressing tumour and inflammatory cells significantly correlated with IMD. Moreover, tumours with higher IMD had higher numbers of infiltrating mast cells and macrophages.
Conclusions: Mononuclear inflammatory cells of the non-specific immune response are recruited to pancreatic cancer tissues independent of the presence of CP-like changes, may influence the metastatic capacity of the cancer cells, and may contribute to the development of tumours with high angiogenic activity.
Keywords: pancreatic cancer; mast cells; macrophages; angiogenesis; tryptase
Abbreviations: bFGF, basic fibroblast growth factor; CSF, colony stimulating factor 1; IMD, intratumorous microvessel density; VEGF, vascular endothelial growth factor
This article has been cited by other articles:
![]() |
T. C. Theoharides Mast Cells and Pancreatic Cancer N. Engl. J. Med., April 24, 2008; 358(17): 1860 - 1861. [Full Text] [PDF] |
||||
![]() |
G. Brideau, M. J. Makinen, H. Elamaa, H. Tu, G. Nilsson, K. Alitalo, T. Pihlajaniemi, and R. Heljasvaara Endostatin Overexpression Inhibits Lymphangiogenesis and Lymph Node Metastasis in Mice Cancer Res., December 15, 2007; 67(24): 11528 - 11535. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gounaris, S. E. Erdman, C. Restaino, M. F. Gurish, D. S. Friend, F. Gounari, D. M. Lee, G. Zhang, J. N. Glickman, K. Shin, et al. Mast cells are an essential hematopoietic component for polyp development PNAS, December 11, 2007; 104(50): 19977 - 19982. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mahadevan and D. D. Von Hoff Tumor-stroma interactions in pancreatic ductal adenocarcinoma Mol. Cancer Ther., April 1, 2007; 6(4): 1186 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. M. Dirkx, M. G. A. oude Egbrink, J. Wagstaff, and A. W. Griffioen Monocyte/macrophage infiltration in tumors: modulators of angiogenesis J. Leukoc. Biol., December 1, 2006; 80(6): 1183 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Duell, D. P. Casella, R. D. Burk, K. T. Kelsey, and E. A. Holly Inflammation, Genetic Polymorphisms in Proinflammatory Genes TNF-A, RANTES, and CCR5, and Risk of Pancreatic Adenocarcinoma. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 726 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jin, J. Su, B. Garmy-Susini, J. Kleeman, and J. Varner Integrin {alpha}4{beta}1 Promotes Monocyte Trafficking and Angiogenesis in Tumors Cancer Res., February 15, 2006; 66(4): 2146 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Udagawa, M. Puder, M. Wood, B. C. Schaefer, and R. J. D'Amato Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells FASEB J, January 1, 2006; 20(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |